Prevalence of arterial hypertension and other cardiovascular risk factors in Romania and Poland - Data from 2 national studies (SEPHAR and NATPOL III plus)

被引:0
|
作者
Dorobantu, M.
Zdrojewski, T.
Badila, E.
Darabont, R. O.
Bandosz, P.
Luca, M. R.
Datcu, G.
机构
[1] Emergency Hosp Bucharest, Bucharest, Romania
[2] Med Univ Gdansk, Gdansk, Poland
[3] Univ Hosp Bucharest, Bucharest, Romania
[4] Bios Diagnost, Bucharest, Romania
[5] Sf Spiridon Hosp, Iasi, Romania
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:S205 / S206
页数:2
相关论文
共 39 条
  • [31] Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: Data from the National Health and Nutrition Examination Survey 1999-2004
    Ostchega, Yechiam
    Paulose-Ram, Ryne
    Dillon, Charles F.
    Gu, Qiuping
    Hughes, Jeffery P.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : 583 - 589
  • [32] Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States - Data from the Third National Health and Nutrition Examination Survey
    Martins, David
    Wolf, Myles
    Pan, Deyu
    Zadshir, Ashraf
    Tareen, Naureen
    Thadhani, Ravi
    Felsenfeld, Arnold
    Levine, Barton
    Mehrotra, Rajnish
    Norris, Keith
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (11) : 1159 - 1165
  • [33] Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: Data from the Third National Health and Nutrition Examination Survey
    Singh, G
    Miller, JD
    Lee, FH
    Pettitt, D
    Russell, MW
    AMERICAN JOURNAL OF MANAGED CARE, 2002, 8 (15): : S383 - S391
  • [35] Empagliflozin improves glycaemic parameters and cardiovascular risk factors in patients with type 2 diabetes: pooled data from four pivotal phase III trials
    Hach, T.
    Gerich, J.
    Salsali, A.
    Kim, G.
    Hantel, S.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2013, 56 : S377 - S378
  • [36] Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: Data from the Adult Diabetes Control and Management
    Sazlina, Shariff-Ghazali
    Mastura, Ismail
    Ahmad, Zaiton
    Cheong, Ai-Theng
    Adam, Bujang-Mohamad
    Jamaiyah, Haniff
    Lee, Ping-Yein
    Syed-Alwi, Syed-Abdul-Rahman
    Chew, Boon-How
    SriWahyu, Taher
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2014, 14 (01) : 130 - 137
  • [37] Prevalence of Cardiovascular Risk Factors and Incidence of Venous and Arterial Thrombosis in Non-Splenectomized Immune Thrombocytopenia Adult Patients in Sweden and France. Results from Two Nationwide Studies
    Ekstrand, Charlotta
    Baricault, Berangere
    Linder, Marie
    Lafaurie, Margaux
    Sailler, Laurent
    Lapeyre-Mestre, Maryse
    Kieler, Helle
    Bahmanyar, Shahram
    Moulis, Guillaume
    BLOOD, 2017, 130
  • [38] Prevalence, geographic distribution and geographic variability of major cardiovascular risk factors in Spain.: Pooled analysis of data from population-based epidemiological studies:: The ERICE study
    Gabriel, Rafael
    Alonso, Margarita
    Segura, Antonio
    Tormo, Maria J.
    Artigao, Luis M.
    Banegas, Jose R.
    Brotons, Carlos
    Elosua, Roberto
    Fernandez-Cruz, Arturo
    Muniz, Javier
    Reviriego, Blanca
    Rigo, Fernando
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (10): : 1030 - 1040
  • [39] Empagliflozin improves glycaemic parameters and cardiovascular risk factors in patients with Type 2 diabetes: pooled data from four randomised, placebo-controlled phase III trials
    Hach, T.
    Gerich, J.
    Salsali, A.
    Kim, G.
    Hantel, S.
    Woerle, H. J.
    Broedl, U. C.
    DIABETIC MEDICINE, 2014, 31 : 64 - 65